chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I  just had a sore in the left arm the next day; This is a spontaneous report from a contactable Nurse (patient). A 68-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiration date not reported), intramuscular on the left arm on 28Dec2020 07:00 at single dose for COVID-19 immunization. Medical history included allergies to PCN/Sulfa. Concomitant medications included calcium and an unspecified allergy pill. The patient reported that she  just had a sore in the left arm the next day on 29Dec2020 and there were no other problems. No treatment was given for the event. The event was reported as non-serious. The patient had no prior COVID vaccination and did not test positive for COVID post vaccination. The patient recovered from the event on an unspecified date.
Patient states lifting her left arm causes pain, inquired if nerves were affected on 01/12/2015.
Fatigue, chills, muscle aches, joint pain, chills, headache, residual cough.
When waking up felt loud ringing in my ears, then developed Vertigo and a Migraine with tongue numbness. Took BENADRYL and NURTEC. Then went to the emergency room and was given a head and neck CT scan, with bloodwork. Was  given a saline IV with ZOFRAN, VALIUM and meclizine, then sent home with the same medicine. Felt better about 3 hours later.
Information has been received from a 58 year old female consumer referring to herself. There were drug reactions/allergies to penicillin, all antibiotics, sulfa drugs and BOTOX. The patient's pertinent medical history included blepharospasm. Sometime during the year of2006, the patient received two vaccine shots of ZOSTAVAX (dose, lot number not provided). It was also stated that it was administered through the intramuscular, which was other-than-indicated in the prescribing information (subcutaneous injection formulation administered by other route and off label use). Concomitant therapies included simvastatin (manufacturer unknown) and lorazepam. She stated that about two years later in 2008, she had an itchiness on the "her lower right side of the back towards the spine" that continued to the reporting day. The outcome of pruritus was reported as not recovered/not resolved. She talked with physician and was given clobetasol propionate for treatment. There were no diagnostics lab studies performed. The outcome of incorrect route of drug administration and off label use was unknown. Additional information has been requested.
eye surgery; Flu like symptoms  6 days after their first dose; Notice that they lost, and have thinner hair after getting their Moderna Covid19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms  6 days after their first dose), ALOPECIA (Notice that they lost, and have thinner hair after getting their Moderna Covid19 vaccine) and EYE DISORDER (eye surgery) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013a21a and 028a21a) for COVID-19 vaccination.     Concomitant products included PROBIOTICS NOS, LEVOTHYROXINE SODIUM (SYNTHROID), LEVOTHYROXINE, NABUMETONE and FUROSEMIDE for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms  6 days after their first dose). In 2021, the patient experienced ALOPECIA (Notice that they lost, and have thinner hair after getting their Moderna Covid19 vaccine). On an unknown date, the patient experienced EYE DISORDER (eye surgery). The patient was treated with Surgery for Eye disorder. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms  6 days after their first dose), ALOPECIA (Notice that they lost, and have thinner hair after getting their Moderna Covid19 vaccine) and EYE DISORDER (eye surgery) outcome was unknown.            The consumer stated that they felt flu like symptoms  6 days after their first dose of Moderna vaccine. The consumer also stated that they noticed hair loss and have thinner hair after getting the Moderna COVID-19 vaccine.  The consumer stated that they received a treatment of steroid shot for their back and underwent eye surgery.  The consumer stated that  they always have adverse reaction to medications.
This case was reported by a physician and described the occurrence of tremors in a 55-year-old female patient who received FLUARIX QUADRIVALENT (batch number GA22N, expiry date 30th June 2015). Previously administered products included influenza vaccine. Concurrent medical conditions included raised liver function tests, infectious mononucleosis and cytomegalovirus infection. On 17th October 2014 14:37, the patient received FLUARIX QUADRIVALENT. On 17th October 2014, 2 hrs after receiving FLUARIX QUADRIVALENT, the patient experienced tremors (serious criteria disability). On an unknown date, the outcome of the tremors was recovering/resolving. The reporter considered the tremors to be possibly related to FLUARIX QUADRIVALENT. Additional information: The subject didn't experience any events following previous vaccinations. Within 2 hours of vaccination, the patient experienced extreme tremors. She has therefore been out of work for 1 month. The patient consulted a neurologist and the reporting physician. At the time of reporting, the concurrent medical conditions were resolved and the liver function test was normal.
N17.9 - Acute kidney failure, unspecified E87.1 - Hypo-osmolality and hyponatremia NASAL CONGESTION COUGH VOMITING WEAKNESS - GENERALIZED
That evening I felt a low fever, aches, weakness, tiredness that lasted 3 days. Injection site had large painful lump that continues, and warm red skin patch the size of a softball that was severely itchy for 3 days. I have had similar, less severe, reactions to prior Anthrax injections
Right arm cellulitis surrounding injection site. Onset within hours of vaccine and progressive spread of redness and swelling over next 24 hours.
COVID breakthrough. Patient presented to the ED on 1/25/22 with complaints of SOB, cough, chest tightness going on for one week. Tested positive for COVID on 1/25/22.
Patient administered DTaP and HAV around noon. Pruritus (generalized) upon arriving home. 12 hrs later developed generalized hives (erythema and swelling). Decreased energy and appetite. Tactile high temps reported, none recorded. Experienced mild wheezing but no respiratory distress. Sxs lasted approximately 48 hours before activity level returned to baseline. Rash resolved within 4 days. Patient not brought to ED. No physician was notified by family. This info all per family report.
sore throat; low grade fever; fatigue; body aches; loss of appetite; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 25-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported, expiry date: not reported, Age at vaccination: 25-year-old) via an unspecified route of administration in Left arm on 09Mar2021 08:15 as DOSE 1, SINGLE for COVID-19 immunization. Medical history included Birth control. Concomitant medications included Albuterol HFA. On 12Mar2021, patient experienced sore throat, low grade fever, fatigue, body ache, loss of appetite. No treatment received for adverse event. Facility type vaccine was hospital. No other vaccine in four weeks. No covid present prior vaccination. Covid was not tested post vaccination. Known allergies: Cillin medications. The outcome of events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
VOMITING, DIZZINES AND SWEATING AFTER  VACCINE.  BLOOD PRESSURE TAKEN, AND PATIENT MONITORED FOR SIGNS OF ANAPHYLAXIS. STORE MANAGEMENT CALLED 911  FOR EMERGENGY, MEDIC ARRIVED AND TOOK OVER THE TREATMENT
patient developed cellulitis at injection site 7 days following vaccination. associated lymphadenopathy. treated with keflex
Spiked a fever of 102.6, body aches, chills, and stomach issues.
I had chills and a fever starting at 5 pm the day of the injection and those broke sometime in the middle of the night. I experienced some stomach discomfort but was not nauseous. However, in the middle of the night, I went to drink water and after the smallest sip I threw up everything in me. When I would use the restroom to poop I would feel a large pressure in my head, but only then and I also experienced muscular pain in my back. I was able to relieve symptoms with Advil. The fever and stomach discomfort was over by 3 am on 3/28. The chills came and went until mid-day on 3/28 and I believe that was with help of the Advil. The occasional pressure in my head only lasted until mid-day 3/28 and the back pain did not go away until the morning of 3/29. Following the vaccine I felt very dehydrated and while I drink lots of water, I had to increase my intake to even more than normal and this feeling was over by the evening of 3/28.  As of today, 3/29 I feel back to 100%.
Administered 07/17/2006. Swelling, redness and hardness baseball size to right upper arm deltoid area. Swelling is less today.
The local site reaction started the next morning as a 2cm circular area of erythema, progressively worsened every day until day 8 (peak). Symptoms at peak included 5cm long x 3cm wide area of erythema, induration, swelling, pain, heat, the very center skin turned yellow, like a blister. It slowly decreased in severity over the next several weeks. Nodular induration at injection site finally resolved 6 weeks later.
Death Chest pain; irreg heart rhythm; evening of vaccine; death on toilet on 1/13/21
Redness and warm to touch (3-4 cm) on right deltoid. DTAP given 11/14/2002 reaction occurred 1 week later 11/20/2002 seen by MD treated Cephalexin (Keflex)
Pt approached registration table requesting a Janssen vaccine. After filling out appropriate paperwork, patient sat down at vaccination table. Nurse used 2 patient identifiers and asked all screening questions. Nurse asked patient twice have you received any previous doses of the COVID-19 vaccine?? patient stated ?no.?   Prior to injection, vaccination team was unable to locate patient records, indicating the client had no profile and no previous COVID-19 vaccine, notifying team to create a new profile. While waiting in observation area, patient stated ?I get shots for my schizophrenia.? Pt also exhibited signs of ?flight of ideas? while conversing with on-site team members.  While attempting to create new profile for patient, an error message and redirected us to a profile matching name and phone number, with a one letter spelling error. Patient had added an ?s? to his last name on his paperwork, preventing team from being successful in accessing his shot records.  Upon opening his records, we noticed he had already received 2 doses of Pfizer vaccine and one dose of Janssen. Notified all necessary personnel. Patient had already left site. No s/s of distress.
shortness of breath, extreme fatique, nausea, malaise, loss of appetite, dizzyness/lightheadedness, weight loss, absominal pain in two places.  Symptoms are still persisting, but if I stay away from alcohol, caffeine, heat, and high intensity exercise, the symptoms stay at bay.
Symptoms: Frequent palpitations starting circa 01/27 Diagnostics: ECG (01/30/2021), Cardiac Echo (02/04/2021), Longterm Heart  Monitor (02/19-02/28/2021) Course: Frequency decreased over time, but palpitations remain
7-13-17  mom called stating that they were on the way to the hospital because patient was not feeling good, headache, sore arm, and temperature of 99.0. I explained to mom that these were common reactions as seen on the VIS. I encouraged her to get her checked out if she wanted and that we could provide any information that they may need. She was very thankful for the call. 7-14-17 I left a message to call me with an update on status. 7-17-17 no return call.
This spontaneous report as received from a registered nurse refers to a 10 week old female patient. The patient has no pertinent medical history and drug reactions or allergies. On 25-Mar-2016, the patient was vaccinated with VAQTA lot # L036300, expiration date 04-NOV-2016, 0.5ml, intramuscularly. At the same visit on 25-MAR-2016, the patient received PENTACEL, PREVNAR 13 and ROTATEQ orally (dose, lot# and expiration date were not reported). On 25-MAR-2016, later on the day, the patient experienced a fever, temperature of 100 degrees (units not provided). The patient received Tylenol for the treatment for the experience. There were no lab diagnostic studies performed except body temperature. The outcome of pyrexia was unknown The relatedness between the event and suspect therapies were not reported. Additional information has been requested.
Rash; This is a spontaneous report from a contactable consumer. The reporter is a patient who was reporting her own experience with the Pfizer Covid-19 vaccine, along with other people reactions. This case is 3  of 4. This case is for the man.  A male patient of an unspecified age received BNT162B2 (unspecified Pfizer vaccine; Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. No medical history and concomitant medications were reported. The patient previously received an unspecified COVID-19 vaccine on an unspecified date as dose 1, single for COVID-19 immunization. On an unspecified date, the patient experienced rash. The reporter mentioned that she did some research online. The second dose of Pfizer and reactions to the Pfizer vaccine and read about 2 people reactions, one is for a woman, and other is this report, about a man, and she does not know the location. It was in the newspaper that he had a rash. It might have been reversed but she does not remember their names. Reporter stated that it was public and was in the newspaper. The outcome of events was unknown.  Information about batch/Lot number has been requested.
Severe pain, nasuea, headache within 6 hours. Erythema and swelling shoulder to wrist lasting 3+ days.
Fever. (102 for over 8 hours) Chills, body hurt so much I had to be in bath most of the day because laying down hurt, stomach ache, headache. Never felt worse in my life. Both of my children got very ill after the second does of Pfizer. I will try to fill out for them too, but do not have time now. One even vomited.
Moderna COVID-19 Vaccine EUA Swelling and hot, itchy rash at injection site.  Delayed reaction, began 8 days after administration of vaccine.  Rash has persisted for 48 hours so far.
1) first few hours - splotches noted on both hands - Inj given @ 5:15 pm 4/22/2008 1) Eye swollen 2) splotches - now hives on chin / both ears/ rash behind both ears, one hive on trunk. 3) C/o difficulty in swallowing 0 fever 0 SOB.
Per mom patient could not move left leg. Contacted our on call physician after hours, and was advised to go to ER.
surgical removal of giant fibroidenoma from left breast. Further plastic surgery required. Tumor was 14cm by 13cm by 6cm.
2 Hours after flu vaccine patient became dizzy and lightheaded.  Symptoms progressed (+) vertigo, (+) weakness. Exam was essentially normal; Benadryl prescribed, symptoms resolved in 36 hours.
feeling like I have the flu; fever; aches; chills; received my COVID-19 booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY), administration date 14Dec2021 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE number unknown, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 14Dec2021, outcome "unknown", described as "received my COVID-19 booster"; INFLUENZA LIKE ILLNESS (non-serious) with onset 15Dec2021, outcome "not recovered", described as "feeling like I have the flu"; PYREXIA (non-serious) with onset 15Dec2021, outcome "not recovered", described as "fever"; PAIN (non-serious) with onset 15Dec2021, outcome "not recovered", described as "aches"; CHILLS (non-serious) with onset 15Dec2021, outcome "not recovered", described as "chills". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A little lump developed on the front side of the arm on Monday, today hot and red but almost flat. Silver dollar size.
2days p/vax pt fussy & vomit; 6/28 pt lethargic & began passing currant-jelly stools; hosp; dx=intussusception; not reduced by barium enema; surgery-ileocolic intussusception reduced & appendectomy
I had body chills fever 103 degree Celsius; body aches; Diarrhea; migraine headache; shivering; This is a spontaneous report from a contactable health care professional, the patient.  A 31-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EK9231) intramuscular in the left arm on 05Jan2021 at 5:30 PM (at the age of 31-year-old) as a single dose for COVID-19 immunization. The patient medical history was not reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. Historical vaccine included Dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EK5730), intramuscular, left arm  on 17Dec2020 for COVID-19 immunization. On 06Jan2021 at 05:00 AM, the patient experienced body chills fever (103 degree Celsius), body aches, diarrhea, migraine headache, shivering.  The events was reported as non-serious. The patient underwent lab test  which included body temperature: 103 degree Celsius. The patient did not receive any treatment for the body chills fever (103 degree Celsius), body aches, diarrhea, migraine headache, shivering. The clinical outcome of the events body chills fever (103 degree Celsius), body aches, diarrhea, migraine headache, shivering was  recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Patient c/o of not feeling, light headed, then became diaphoretic. He was placed into a wheel chair and taken to the medical eval. area. and allowed to lay on the cart.  VS: 98.7, 68,18, 118/70. He was offered an ice pack and a bottle of water (drank all 16 oz). He reported feeling better around 2:18 PM, encouraged to sit up for a few minutes, then aloud to walk around to make sure sure he felt sturdy. He left at 2:32 PM Pt. report similar episodes with blood draws. Instructed to make the nurse aware for his 2nd visit so vaccination can be given with him laying down.
Date the vial was initially stored in the refrigerator on 10 JUL 2023 and Dose administered after 30-day Use by Date on 14 Aug 2023; No adverse event; patient received expired 2nd booster dose Moderna COVID-19 vaccine 5 days after 30-day Use By Date, on 14AUG2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received expired 2nd booster dose Moderna COVID-19 vaccine 5 days after 30-day Use By Date, on 14AUG2023), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 10 JUL 2023 and Dose administered after 30-day Use by Date on 14 Aug 2023) and NO ADVERSE EVENT (No adverse event) in a 70-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7184B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Aug-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 2.5 milliliter. On 14-Aug-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received expired 2nd booster dose Moderna COVID-19 vaccine 5 days after 30-day Use By Date, on 14AUG2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 10 JUL 2023 and Dose administered after 30-day Use by Date on 14 Aug 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received expired 2nd booster dose Moderna COVID-19 vaccine 5 days after 30-day Use By Date, on 14AUG2023), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 10 JUL 2023 and Dose administered after 30-day Use by Date on 14 Aug 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient received expired 2nd booster dose Moderna COVID-19 vaccine 5 days after 30-day Use By Date, on 14AUG2023) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 10 JUL 2023 and Dose administered after 30-day Use by Date on 14 Aug 2023).    No concomitant medications were provided.  The vial did not undergo any temperature excursions.  Dosage text for suspect product was reported as unknown.  No treatment medication was provided.
C/O DIZZINESS,BP 125/83 HR71, O2SAT 97% R20,PO FLUID OFFERED ACCEPTED,RECLINED IN CAR CONTINUES TO BE MONITORED.   RE ASSESSED BP134/88 HR 70, STATES HE FEELS BETTER ,DROVE HOME.
Side is hurting; its like a pressure in what caller guesses is her uterus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old female patient received bnt162b2 (Formulation: Solution for injection), administered in arm right, administration date 07May2021 (Lot number: EL10170, Expiration Date: 31Aug2021) at the age of 54 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 07May2021, outcome "recovering", described as "Side is hurting"; FEELING ABNORMAL (non-serious) with onset 07May2021, outcome "recovering", described as "its like a pressure in what caller guesses is her uterus".  Additional information: Caller is a consumer inquiring if anybody has ever reported any side effects like caller is presenting. Caller's side is hurting.  Caller got the first dose Pfizer Covid Vaccine this morning, 07May2021. Side is hurting: Caller states its like a pressure in what caller guesses is her uterus.  It is making caller feel like she has to go to the bathroom.  Caller reports she has been drinking a lot of water.  Caller is in pain on her side all of a sudden and the pain is not going away. Caller reports her side hurting is ongoing and has improved. Caller wanted to see if anyone reported this event.  Caller wants to go lay down.  Caller declines to complete l Form.  Caller states she wants to go lay down.  Caller would like to speak with medical information.  No further information is provided.    No follow-up attempts are needed. No further information is expected.